Feds warning women of 'egregious' marketing of 'vaginal rejuvenation' laser procedure
The FDA says a growing number of manufacturers are marketing what's called "vaginal rejuvenation" procedures for women, which promise to treat conditions related to menopause, urinary incontinence or sexual functions.
The procedures use lasers to destroy and reshape vaginal tissue. While the laser devices have been approved by the FDA to treat pre-cancerous cervical or vaginal tissue and warts, they have not been approved for "rejuvenation" procedures.
To make matters worse, the FDA says some women being targeted are those who have been treated for cancer, calling the move "egregious."
"In some cases, these devices are being marketed for this use to women who have completed treatment for breast cancer and are experiencing symptoms caused by early menopause. The deceptive marketing of a dangerous procedure with no proven benefit, including to women who’ve been treated for cancer, is egregious," the FDA states.
The FDA says it has found published reports of burns, scarring, and recurring or chronic pain. The agency is warning women of the deceptive marketing and has notified seven device manufacturers of its concerns.